» Articles » PMID: 4331802

The Effects of Thrombin on Adenyl Cyclase Activity and a Membrane Protein from Human Platelets

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1972 Jan 1
PMID 4331802
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Washed human platelets were incubated with 0.1-1.0 U/ml human thrombin and the effects on adenyl cyclase activity and on a platelet membrane protein (designated thrombin-sensitive protein) were studied. Adenyl cyclase activity was decreased 70-90% when intact platelets were incubated with thrombin. The T(1/2) for loss of adenyl cyclase activity was less than 15 sec at 1 U/ml thrombin. There was no decrease of adenyl cyclase activity when sonicated platelets or isolated membranes were incubated with these concentrations of thrombin. Loss of adenyl cyclase activity was relatively specific since the activities of other platelet membrane enzymes were unaffected by thrombin. Prior incubation of platelets with dibutyryl cyclic adenosine monophosphate (AMP), prostaglandin E(1), or theophylline protected adenyl cyclase from inhibition by thrombin. Incubation of intact but not disrupted platelets with thrombin resulted in the release of thrombin-sensitive protein from the platelet membrane. The rapid release of this protein (T(1/2) < 15 sec) at low concentrations of thrombin suggested that removal of thrombin-sensitive protein from the platelet membrane is an integral part of the platelet release reaction. This hypothesis is supported by the parallel effects of thrombin on adenyl cyclase activity and thrombin-sensitive protein release in the presence of dibutyryl cyclic AMP, prostaglandin E(1), and theophylline at varying concentrations of thrombin.

Citing Articles

Platelets and cancer: a casual or causal relationship: revisited.

Menter D, Tucker S, Kopetz S, Sood A, Crissman J, Honn K Cancer Metastasis Rev. 2014; 33(1):231-69.

PMID: 24696047 PMC: 4186918. DOI: 10.1007/s10555-014-9498-0.


Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets.

Fujimoto T, OHara S, Hawiger J J Clin Invest. 1982; 69(6):1212-22.

PMID: 6282932 PMC: 370193. DOI: 10.1172/jci110560.


Retention of the glycoprotein IIb-IIIa complex in the isolated platelet cytoskeleton. Effects of separable assembly of platelet pseudopodal and contractile cytoskeletons.

Wheeler M, Cox A, Carroll R J Clin Invest. 1984; 74(3):1080-9.

PMID: 6088580 PMC: 425267. DOI: 10.1172/JCI111475.


The effect of an inhibitor of the thrombin-fibrinogen reaction on thrombin-induced blood-platelet aggregation.

Flengsrud R, Eika C, Prydz H Biochem J. 1972; 130(3):899-900.

PMID: 4677168 PMC: 1174529. DOI: 10.1042/bj1300899.


Induction of the platelet release reaction by phytohemagglutinin.

Tollefsen D, FEAGLER J, MAJERUS P J Clin Invest. 1974; 53(1):211-8.

PMID: 4357613 PMC: 301456. DOI: 10.1172/JCI107540.


References
1.
EMMONS P, Hampton J, Harrison M, HONOUR A, Mitchell J . Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J. 1967; 2(5550):468-72. PMC: 1842033. DOI: 10.1136/bmj.2.5550.468. View

2.
Emmelot P, Bos C . Studies on plasma membranes. 3. Mg2+-ATPase,(Na+-K+-Mg2+)-ATPase and 5'-nucleotidase activity of plasma membranes isolated from rat liver. Biochim Biophys Acta. 1966; 120(3):369-82. DOI: 10.1016/0926-6585(66)90304-9. View

3.
Krishna G, Weiss B, Brodie B . A simple, sensitive method for the assay of adenyl cyclase. J Pharmacol Exp Ther. 1968; 163(2):379-85. View

4.
MAJERUS P, Smith M, Clamon G . Lipid metabolism in human platelets. I. Evidence for a complete fatty acid synthesizing system. J Clin Invest. 1969; 48(1):156-64. PMC: 322201. DOI: 10.1172/JCI105964. View

5.
CHASE L, FEDAK S, Aurbach G . Activation of skeletal adenyl cyclase by parathyroid hormone in vitro. Endocrinology. 1969; 84(4):761-8. DOI: 10.1210/endo-84-4-761. View